Publication | Closed Access
Galantamine for Alzheimer’s Disease and Mild Cognitive Impairment
95
Citations
0
References
2007
Year
Neurodegenerative DiseasesAlzheimer's DiseaseMedicineNeurochemical BiomarkersNeuroscienceMild Cognitive ImpairmentNeurodegenerationPharmacologyTreatment
No additional data available for this publication yet. Check back later!